An open-label, single-arm, phase Ib exploratory study to evaluate the safety and efficacy of golidocitinib in combination with anti-PD-1 in locally advanced or metastatic non-small cell lung cancer (NSCLC) treated with anti-PD-1 containing regimens

被引：0

作者：

Zhong, H. ^{[1
]}

Zhang, X. ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Resp & Crit Care Med Dept, Shanghai, Peoples R China

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

126TiP

引用

页数：3